Revised Document Posted: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012, Correction, 41190 [2012-17002]
Download as PDF
<![CDATA[
pmangrum on DSK3VPTVN1PROD with NOTICES
41190
Federal Register / Vol. 77, No. 134 / Thursday, July 12, 2012 / Notices
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda
for the Subcommittee meeting includes:
revisiting the Board’s dose
reconstruction review process; dose
reconstruction program quality
management and assurance activities,
including an overview of contractor
quality management system and an
update on the results of NIOSH internal
dose reconstruction blind reviews; dose
reconstruction issues from NIOSH 10year review, including review of
resource impact of possible changes to
efficiency process and plans for a
NIOSH Division of Compensation
Analysis and Support claimant
favorability analysis; discussion of dose
reconstruction cases under review (sets
8–9, cases with Category A findings
from sets 10–13, Savannah River Site
cases from sets 10–13); and preselection of set 16 dose reconstruction
cases to be reviewed by the Board’s
technical support contractor.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted. Any written comments
received will be provided at the meeting
and should be submitted to the contact
person below well in advance of the
meeting.
Contact Person for More Information:
Theodore Katz, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton
Road, Mailstop E–20, Atlanta, Georgia
30333, Telephone: (513) 533–6800, Toll
Free 1 (800) CDC–INFO, Email:
ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
VerDate Mar<15>2010
15:39 Jul 11, 2012
Jkt 226001
Dated: July 6, 2012.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2012–17041 Filed 7–11–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–190]
Revised Document Posted: NIOSH List
of Antineoplastic and Other Hazardous
Drugs in Healthcare Settings 2012,
Correction
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: A notice of issuance of Final
Guidance Publication was published in
the Federal Register June 27, 2012, (77
FR 38297). This notice is corrected as
follows:
AGENCY:
On page 38297, the Docket number
has been changed to NIOSH–190.
FOR FURTHER INFORMATION CONTACT:
Barbara MacKenzie, NIOSH, Robert A.
Taft Laboratories, 4676 Columbia
Parkway, MS–C26, Cincinnati, OH
45226, Telephone (513) 533–8132, email
hazardousdrugs@cdc.gov.
Dated: July 6, 2012.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2012–17002 Filed 7–11–12; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Office of Clinical and Preventive
Services Funding Opportunity:
National HIV Program for Enhanced
HIV/AIDS Screening and Engagement
in Care
Indian Health Service, HHS
ACTION: Notice: correction.
AGENCY:
The Indian Health Service
published a document in the Federal
Register on June 19, 2012, concerning
Announcement Type: New. Funding
Announcement Number: HHS–2012–
SUMMARY:
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
IHS–OCPS–HIV–0001. Catalog of
Federal Domestic Assistance Number:
93.933. The document contained five
incorrect dates.
FOR FURTHER INFORMATION CONTACT: Dr.
Charlene Avery, Director, Office of
Clinical and Preventative Services,
Indian Health Service, 801 Thompson
Avenue, Suite 300, Reyes Building,
Rockville, MD 20852, Telephone 301–
443–1190. (This is not a toll-free
number.)
Corrections
In the Federal Register of June 19,
2012, in FR DOC 2012–14891, on page
36550, in the third column, under the
heading ‘‘Dates: Key Dates:’’
‘‘Application Deadline Date: July 16,
2012.’’ should read ‘‘July 20, 2012.’’ On
page 36552, in the first column, under
the heading ‘‘Proof of Non-Profit
Status’’; ‘‘A copy of the 501(c)(3)
Certificate must be received with your
application submission by the deadline
date of July 16, 2012.’’ should read ‘‘A
copy of the 501(c)(3) Certificate must be
received with your application
submission by the deadline date of July
20, 2012.’’ On page 36553, in the first
column, under the heading ‘‘3.
Submission Dates and Times’’
‘‘Applications must be submitted
electronically through Grants.gov by
12:00 a.m., midnight Eastern Daylight
Time (EDT) on July 16, 2012’’ should
read ‘‘Applications must be submitted
electronically through Grants.gov by
12:00 a.m., midnight Eastern Daylight
Time (EDT) on July 20, 2012.’’ On page
36553, in the second column, under the
heading ‘‘Proof of Non-Profit Status:’’
‘‘Due Date July 16, 2012’’ should read
‘‘Due Date July 20, 2012.’’ On page
36553, in the third column, under the
fourth bullet ‘‘If the waiver is approved,
the application should be sent directly
to the DGM by the deadline date of July
16, 2012.’’ should read ‘‘If the waiver is
approved, the application should be
sent directly to the DGM by the deadline
date of July 20, 2012.’’
Dated: July 2, 2012.
Yvette Roubideaux,
Director, Indian Health Service.
[FR Doc. 2012–17047 Filed 7–11–12; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Office of Urban Indian Health
Programs Funding Opportunity: Title V
HIV/AIDS Program
AGENCY:
E:\FR\FM\12JYN1.SGM
Indian Health Service, HHS.
12JYN1
]]>Agencies
[Federal Register Volume 77, Number 134 (Thursday, July 12, 2012)]
[Notices]
[Page 41190]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-17002]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-190]
Revised Document Posted: NIOSH List of Antineoplastic and Other
Hazardous Drugs in Healthcare Settings 2012, Correction
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: A notice of issuance of Final Guidance Publication was
published in the Federal Register June 27, 2012, (77 FR 38297). This
notice is corrected as follows:
-----------------------------------------------------------------------
On page 38297, the Docket number has been changed to NIOSH-190.
FOR FURTHER INFORMATION CONTACT: Barbara MacKenzie, NIOSH, Robert A.
Taft Laboratories, 4676 Columbia Parkway, MS-C26, Cincinnati, OH 45226,
Telephone (513) 533-8132, email hazardousdrugs@cdc.gov.
Dated: July 6, 2012.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2012-17002 Filed 7-11-12; 8:45 am]
BILLING CODE 4163-19-P
